AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER

Keryx’s NDA for kidney drug accepted for filing by US FDA

 NDA  Comments Off on Keryx’s NDA for kidney drug accepted for filing by US FDA
Oct 102013
 

Keryx Biopharmaceuticals has announced that its new drug application (NDA) for Zerenex (ferric citrate coordination complex) has been accepted for filing by the US FDA.

Keryx’s NDA for kidney drug accepted for filing by US FDA

http://www.pharmaceutical-technology.com/news/newskeryxs-nda-kidney-drug-accepted-filing-us-fda?WT.mc_id=DN_News

 

Zerenex aims to lower blood levels of phosphorous in patients undergoing kidney dialysis.

Share
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: